Venmax Drugs And Pharmaceuticals Ltd Share Price & Stock Analysis

Venmax Drugs And Pharmaceuticals Ltd (BSE: 531015) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹21 Cr, it ranks #4,408 by market cap among the 6,197 Indian listed companies on FinBizNet, and #58 of 63 in Pharmaceuticals. At ₹13.55 (as of 16 Nov 2026), the share price is 57.0% below its 52-week high of ₹31.49 and 8.3% above its 52-week low of ₹12.51. The share price is down 46.0% over one year and down 14.2% over three months.

Key Metrics

Current Price₹13.55
Market Cap₹21 Cr
BSE Code531015
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio68.2
Return on Assets0.82%
52-Week Range₹12.51 – ₹31.49
1-Year Price Change-46.0%
3-Month Price Change-14.2%
Beta (1Y)0.24
HeadquartersHyderabad, Telangana
Websitewww.venmaxdrugs.com

Shareholding and Delivery

Delivery averaged 76.8% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Venmax Drugs And Pharmaceuticals Ltd

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API’s. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.

Products and Services

1. Pharmaceutical-This segment engages in the manufacture and sale of bulk drugs intermediates primarily in India. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceutical-100%

Venmax Drugs And Pharmaceuticals Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Venmax Drugs And Pharmaceuticals Ltd₹21 Cr68.2——-46.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd is trading at ₹13.55, with a market capitalisation of ₹21 Cr.

Which sector does Venmax Drugs And Pharmaceuticals Ltd belong to?

Venmax Drugs And Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd has a P/E of 68.2.

What is the stock symbol of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd is listed on the BSE under the scrip code 531015.

How has Venmax Drugs And Pharmaceuticals Ltd's share price moved over the past year?

Venmax Drugs And Pharmaceuticals Ltd's share price is down 46.0% over one year and down 14.2% over three months. Its 52-week range is ₹12.51 to ₹31.49.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.